LOPES, T. M. S.; LOPES, Thays Milena Silva.
Abstract:
Miconia albicans is one of the most important species of the Melastomataceae family, known
as “maria-branca”, “lacre-branco”, “folha-branca” and “canela-de-velho”. According to reports
in the literature, its popular use indication is for the treatment of rheumatism, arthrosis, arthritis,
vitiligo, genitourinary infections, regulation of heart rhythm, antiophidic, prevention of heart
attacks, relief of febrile symptoms, and for gastric problems. Given this reported therapeutic
diversity, the present study aims to review the literature on the Miconia albicans plant and its
therapeutic potential. The study was based on an integrative review without time limitation in
the scientific databases Pubmed, ScienceDirect, Google Scholar and the BVS. Of the 113
articles retrieved from the databases, 31 were selected to compose the results, in which phenolic
compounds and terpenes were identified as the most prevalent classes of secondary metabolites.
Conditions related to joint pain such as arthritis, osteoarthritis and pain in the spine/back were
evidenced, as the problems most related to its use. Anti-inflammatory and antimicrobial
activities were the most frequent among the studies, but positive results were also obtained for
antioxidant, anxiolytic, anticonvulsant, analgesic, antidiabetic and antiophidic properties. In
addition to toxicity against Artemia salina, THP-1 cells and against lung fibroblast cell lineage.
Possible mechanisms of action were also attributed, the antioxidant linked to the scavenging of
free radicals, anti-inflammatory inhibition of arachidonic acid cascade enzymes, blocking the
increase in inflammatory cytokine levels, decreased levels of adipocytokines and soluble TNF
receptors -α, antidiabetic inhibition of protein tyrosine phosphatase 1B and anxiolytic
relationship with GABAergic receptors. In view of this, the literature points to the need for
more studies, for a reliable confirmation, in which a safe use of the plant can be guaranteed and
the opening of a range of new drug therapy options for the population, since its results are
promising and contribute to the discovery of new drugs.